Background and activities
BSc in Biology from University in Mostar, afterwards MSc in Molecular Medicine at NTNU, and now a PhD student in Molecular Medicine at NTNU since 2012.
Aida has a Bachelor`s degree in Biology from the University “Dzemal Bijedic” in Mostar, Bosnia and Herzegovina. In 2010 Aida moved to Trondheim, where she earned a Master`s degree in Molecular Medicine in Anders Sundan`s Multiple Myeloma group. Her MSc thesis is titled “The role of CD1d in survival and growth of hyperdiploid multiple myeloma cells”.
Aida is now working on her PhD in Geir Slupphaug´s Proteomics group, titled “Biomarker discovery in Multiple Myeloma progression by quantitative proteomics”. The goal of her study is to identify protein biomarkers that predict and prevent the progression from the asymptomatic premalignant disorder called Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma.
Scientific, academic and artistic work
A selection of recent journal publications, artistic productions, books, including book and report excerpts. See all publications in the database
- (2017) Proteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia. OncoTarget. vol. 8 (12).
- (2016) VOLIN and KJON—Two novel hyperdiploid myeloma cell lines. Genes, Chromosomes and Cancer. vol. 55 (11).
- (2015) Modulation of cell metabolic pathways and oxidative stress signaling contribute to acquired Melphalan resistance in multiple myeloma cells. PLoS ONE. vol. 10 (3).
- (2013) An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells. PLoS ONE. vol. 8 (2).